Founder ends Executive Chairman term, director resigns, new CEO appointed

Management Changes View source PDF Explain this filing

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹217.68

prior close

₹218.06

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+1.7% vs market

Pharmaceuticals peers, median of 173sector-0.8%+1.2% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.1

15m

-0.7

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4-1.3+1.7-0.8+1.2

Next day

-1.2-1.3+0.1-1.3+0.0

+3.9+0.0+3.9-0.4+4.3

+3.8-0.2+4.0-0.1+4.0

-2.4-3.0+0.6-3.1+0.7

-2.0-2.7+0.7-3.1+1.1

-1.8-1.7-0.1-3.1+1.3

15d

-11.2-8.9-2.3-6.9-4.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board meeting outcome covers three changes effective October 1, 2026: founder Jai Hiremath's term as Executive Chairman ends and he is given an honorary Chairman Emeritus role for 5 years. Non-Executive Director Sugandha Hiremath resigned effective September 30, 2026 citing personal commitments. Anish Swadi, who has been with Hikal since 2021, is appointed as CEO-Animal Health and Specialty Ingredients.

Likely market impact

Major leadership transition at founder-led Hikal. Founder steps back to honorary role, family director exits board, internal hire made for divisional CEO.